We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




High-Definition Volume-Rendering Software Improves Ease-of-Integration, Time-to-Market

By MedImaging International staff writers
Posted on 31 Dec 2014
Print article
Image: Fovia’s high-definition volume-rendering (HDVR) is a CPU-based, advanced visualization technology platform designed for OEMs. The CPU-based technology provides critical information “on-the-fly” via the cloud, local networks, or as an integrated component of existing architectures (Photo courtesy of Fovia).
Image: Fovia’s high-definition volume-rendering (HDVR) is a CPU-based, advanced visualization technology platform designed for OEMs. The CPU-based technology provides critical information “on-the-fly” via the cloud, local networks, or as an integrated component of existing architectures (Photo courtesy of Fovia).
New high-definition volume rendering (HDVR) software provides the ease-of-integration and quick time-to-market required in the current fast-paced imaging environment.

Fovia Medical, Inc. (Palo Alto, CA, USA), a developer of volume-rendering technology, presented an expanded high-definition volume-rendering (HDVR) software range, featuring F.A.S.T. HDVR, at the 100th scientific assembly and annual meeting of the Radiological Society of North America (RSNA), held November 30 to December 5, 2014 , in Chicago (IL, USA). Original equipment manufacturers (OEMs) can utilize central processing unit (CPU)-based F.A.S.T. HDVR to enhance their visualization rapidly and cost-effectively.

F.A.S.T. HDVR provides excellent quality, performance, and scalability for rendering real-time, high-fidelity two-dimensional (2-D), 3-D, 4-D, and 5-D anytime, anywhere. Fovia’s fully customizable OEM product range includes: F.A.S.T. HDVR Web-Zero footprint HTML5 viewer; F.A.S.T. HDVR Vision, a distributable turnkey application; F.A.S.T. HDVR SDK, which is a native integration toolkit; F.A.S.T. HDVR RapidPrint high-fidelity 3D printing ; F.A.S.T. HDVR Mobile3D for mobile devices; and F.A.S.T. HDVR Stereo immersive virtual reality.

The HDVR software enables advanced diagnostic applications, custom workflows and high-performance interactive imaging. Fovia provides a flexible, long-term solution for enterprise-wide or cloud-based deployment.

“Incorporating the gold standard in imaging by integrating F.A.S.T. HDVR improves overall product workflows and enhances patient outcomes,” said David Wilkins, vice president, business development, Fovia. “OEMs are able to maintain the functionality of their existing product line via a F.A.S.T. HDVR integration, and stay in control of their development timeline with bespoke customization, turn-key solutions and multidimensional scalability. Whether it’s for an enterprise-wide, multi-facility network, a stand-alone workstation or a cloud-based mobile platform, F.A.S.T. HDVR delivers the quality, performance, and flexibility needed in today’s market.”

Related Links:

Fovia Medical


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound Doppler System
Doppler BT-200
New
X-Ray Detector
FDR-D-EVO III
New
Ultrasound System
Voluson Signature 18

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.